Regulation of glucose and energy metabolism in cancer cells by hypoxia inducible factor 1

Cellular Respiration and Carcinogenesis

Volumn , Issue , 2009, Pages 73-90

  Ferreira, Túlio César ^a   Campos, Élida Geralda ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Glucose transporter; Glycolysis; HIF 1; HIF 1 ; Hypoxia response element (HRE); Lactate; Prolyl hydroxylases; Regulation of gene expression; von Hippel Lindau tumor suppressor protein (pVHL)

Indexed keywords

EID: 80755188301     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-435-3_6     Document Type: Chapter

References (30)

1. Semenza GL. Expression of hypoxia-inducible factor 1: Mechanisms and consequences. Biochem Pharmacol 2000;59: 47-53
2. Metzen E, Berchner-Pfannschmidt U, Stengel P, et al. Intracellular localisation of human HIF-1- hydroxylases: Implications for oxygen sensing. J Cell Sci 2003; 116:1319-1326
3. Berra E, Benizri E, Ginouvès A, Volmat V, Roux D, Pouysségur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1- in normoxia. EMBO J 2003; 22:4082-4090
4. Jewell UR, Kvietikova I, Scheid A, Bauer C,Wenger RH, Gassmann M. Induction of HIF-1- in response to hypoxia is instantaneous. FASEB J 2001; 15:1312-1314
5. Höpfl G, Ogunshola O, Gassmann M. HIFs and tumors - causes and consequences. Am J Physiol Regul Integr Comp Physiol 2004; 286:R608-R623
6. Elstrom RL, Bauer DE, Buzzai M, et al. AKT stimulates aerobic glycolysis in cancer cells. Cancer Res 2004; 64:3892-3899
7. Kim SH, Park JA, Kim JH, et al. Characterization of ARD1 variants in mammalian cells. Biochem Biophys Res Commun 2006; 340:422-427
8. Brüne B, Zhou J. The role of nitric oxide (NO) is stability regulation of hypoxia inducible factor-1 (HIF-1). Current Med Chem 2003; 10:845-855
9. Lee J-W, Bae S-H, Jeong J-W, Kim S-H, Kim K-W. Hypoxia-inducible factor (HIF-1)-: Its protein stabilization and biological functions. Exp Mol Med 2004; 36:1-12
10. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signalling at the consensus HRE. Sci Stke 2005;re12
11. Pouyssegur J, Mechta-Grigoriou F. Redox regulation of the hypoxia-inducible factor. Biol Chem 2006; 387:1337-1346
12. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999; 59:5830-5835
13. Semenza GL. HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr 2007; 39:231-234
14. Warburg O. On the origin of cancer cells. Science 1956; 123:309-314
15. Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 2002; 277:23111-23115
16. Iyer NV, Kotch LE, Agani F, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1-. Genes Dev 1998; 12:149-162
17. Mathupala SP, Ko YH, Pedersen PL. Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 2006; 25:4777-4786
18. Funasaka T, Yanagawa T, Hogan V, Raz A. Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia. FASEB J 2005; 19:1422-1430
19. Minchenko OH, Ochiai A, Opentanova IL, et al. Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors. Biochimie 2005; 87:1005-1010
20. Salceda S, Beck I, Caro J. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia. Arch Biochem Biophys 1996; 334:389-394
21. Lu S, Gu X, Hoestje S, Epner DE. Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochim Biophys Acta 2002; 1574:152-156
22. Said HM, Hagemann C, Stojic J, et al. GAPDH is not regulated in human glioblastoma under hypoxic conditions. BMC Mol Biol 2007; 8:55
23. Yeo EJ, Chun YS, Cho YS, et al. YC-1: A potential anticancer drug targeting hypoxiainducible factor 1. J Natl Cancer Inst 2003; 95:516-525
24. Kress S, Stein A, Maurer P, et al. Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol 1998; 124:315-320
25. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3:177-185
26. Shim H, Dolde C, Lewis BC, et al. c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth. Proc Natl Acad Sci USA 1997; 94:6658-6663
27. Hayashi M, Sakata M, Takeda T, et al. Induction of glucose transporter 1 expression through hypoxia-inducible factor 1 under hypoxic conditions in trophoblast-derived cells. J Endocrinol 2004; 183:145-154
28. Selak MA, Armour SM, MacKenzie ED, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-Alpha prolyl hydroxylase. Cancer Cell 2005; 7:77-85
29. Pollard PJ, Briere JJ, Alam NA, et al. Accumulation of Krebs cycle intermediates and overexpression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 2005; 14:2231-2239
30. Patiar S, Harris AL. Role of hypoxia-inducible factor-1alpha as a cancer therapy target. Endocr Relat Cancer 2006; 13(Suppl 1):S61-S75